THE UNIVERSITY OF NOTTINGHAM
ROLE PROFILE
THIS DOCUMENT CONTAINS DETAILS FOR
AN NIHR-FUNDED ACADEMIC CLINICAL ASSISTANT PROFESSOR (ACL)
WHICH WILL BE OFFERED TO ONE SUCCESSFUL CANDIDATE
IN EITHER GASTROENTEROLOGY OR MEDICAL ONCOLOGY
FOR DETAILS OF THE ACL OPPORTUNITY IN GASTROENTEROLOGY
Please see post details from Pages 2 – 11 inclusive and Appendices Pages 20-26
FOR DETAILS OF THE ACL OPPORTUNITY IN MEDICAL ONCOLOGY
Please see post details from Pages 12 – 19 inclusive and Appendices Pages 20-26
Page 1 of 26
THE UNIVERSITY OF NOTTINGHAM
ROLE PROFILE
Job Title:
NIHR Academic Clinical Assistant Professor (ACL) in
Gastroenterology
School/Department:
School of Medicine
- NIHR Biomedical Research Unit Nottingham Digestive Diseases Centre
Salary:
£31,301 - £54,199 per annum, depending on skills and experience
Contract Status:
This post will be offered on a fixed-term contract for a period of 4 years (if
full-time; up to a maximum of 6 years part-time) or until award of
Certificate of Completion of Training (CCT), whichever is the shorter
Successful applicants must be in post before 31 March 2015
Hours of Work:
Full-time or Part-time (minimum 0.6 FTE)
Location:
Queen’s Medical Centre, Nottingham
Reporting to:
Professor Guru Aithal, Head of Nottingham Digestive Diseases Centre
The University of Nottingham seeks applications for an NIHR-funded Academic Lecturer (ACL) in
Gastroenterology. The post is offered in competition with eligible applicants in Medical Oncology.
Academic Clinical Lectureships (ACL) in Gastroenterology provide advanced integrated academic and
clinical training for those pursuing a career in Academic Gastroenterology. The post will have a strong
research commitment in gastroenterology research in conjunction with clinical training.
The Post
In this NIHR Academic Clinical Lectureship in Gastroenterology, the Clinical Lecturer will spend 50% of
their time consolidating their clinical experience in General Internal Medicine (GIM) and
Gastroenterology on the Health Education East Midlands (North) Training programme centred around
Nottingham. The remaining 50% of their time will be spent in research. Time allocated to training and
to academic work may be annualised, i.e. taken in blocks, as appropriate to successful candidate’s
clinical and research training needs. The appointee will become a member of the well- developed
Clinical Academic Training Programme in the School of Medicine, University of Nottingham
(www.nottingham.ac.uk/go/catp). The programme provides support in integrated clinical academic
training, with research funding applications, through networking, mentorship and with an annual
research conference bursary.
Whilst the post will be offered on a fixed term contract for a period of up to 4 years, or until award of
CCT whichever is shorter, the Clinical Lecturer would be expected to develop plans for a post-doctoral
or clinician scientist award, which may shorten the lectureship. On completion of their clinical training,
the trainee should be fully qualified to apply for Clinical Associate Professor / Honorary Consultant
posts. An Honorary Specialty Registrar contract will be sought from Nottingham University Hospitals
NHS Trust.
Details of the academic and clinical aspects of the post are given below.
Academic component of the Academic Clinical Lecturer (ACL) posts
During the academic component of the post, the ACL will further develop their academic skills at
postdoctoral level, build on their research in Gastroenterology, undertake research, develop their own
research programme and compete for external grant funding. More details are given below.
Page 2 of 26
The academic part of the training will be tailored to individual needs of the Lecturer and their research
interests. The ACL would be expected to further develop their track record in research and will have
access to the research facilities of the Academic Division which has excellent laboratory, statistical and
technical support. They will be expected to undertake research and, as part of their research portfolio,
they will be expected to develop skills in research supervision through the supervision of the research
component in the 3rd year of the BMedSci medical student degree. The ACL’s personal research
programme would be expected to fit broadly within the research themes of the of Nottingham Digestive
Diseases Centre, described in more detail below.
Each ACL will have an academic supervisor with they will formulate their individual academic
programme. The ACL will be expected to attend:






The weekly Gastroenterology educational meeting and case conference.
The regular Gastroenterology research meetings.
Other research meetings at the discretion of the supervisor.
Conduct research.
Publish at least one paper or at least two abstracts describing original research each year
In most cases, to apply for a further, peer-reviewed externally-funded post-doctoral training
award (such as a Clinician Scientist Award, or an Intermediate or Senior Research Fellowship
from the Medical Research Council, NIHR a major charity such as the Wellcome Trust, or
another funding body).
Office and laboratory accommodation will be provided of Nottingham Digestive Diseases Centre at the
Queen’s Medical Centre site of the University of Nottingham’s School of Medicine.
Research interests and disciplines available at Nottingham/Derby in the Nottingham
Digestive Diseases Biomedical Research Unit (NDD BRU)
The research interests of the NDD BRU are broad covering luminal gastroenterology, hepatology and
gastrointestinal surgery. There is specific expertise in inflammatory bowel disease (IBD), peptic ulcer
and H. pylori associated diseases, C. difficile infection, neurogastroenterology, cirrhosis and portal
hypertension, non-alcoholic fatty liver disease, genetics of liver injury and chronic hepatitis C.
Professor Guru Aithal, co-chairs the international drug-induced liver injury (DILI) consortium which has
led to recent discoveries in genetic susceptibility to DILI; there is an on-going project investigating
genetic and circulating biomarkers of DILI. He also established a translational research group in
Nottingham investigating novel tests to stratify NAFLD, life style and pharmacological interventions in
NAFLD. In collaboration with SPMMRC, there are a number of work streams developing MR
methodology to evaluate chronic liver diseases.
Dr Gordon Moran sub-specialises in IBD. He has collaborative projects with the Sir Peter Mansfield
Magnetic Resonance Centre studying the neurohormonal axis using MRI technology in IBD. Parallel
work with Professor Spiller is investigating the altered gut motility in Crohn’s disease patients. Other
therapies to enhance food intake and body composition in IBD are being explored with the MRC Centre
for Musculoskeletal Ageing. He is principal investigator in a number of IBD-related pharmaceutical-led
studies at the NDD BRU.
Dr Tim Card and Dr Joe West conduct a wide range of GI epidemiology and observational studies in
many areas including IBD, GI bleeding, celiac disease and liver diseases.
Professor Krish Ragunath is an academic endoscopist interested in advanced imaging and pre-cancer
detection and treatment in the GI tract.
Professor John Atherton conducts translational and basic research in Helicobacter pylori pathogenesis
and mechanisms of upper GI diseases.
Dr Neil Guha, Associate Professor in Hepatology is an expert in the development and evaluation of
biomarkers in liver disease; he developed the concept of ‘clinical utility model’ of non-invasive markers
of liver fibrosis; his current work includes stratification of chronic liver disease using tissue, serum and
imaging markers both in primary care and hospital based cohorts. Dr Neil Guha and Prof Guru Aithal
were winners of the National NHS Innovation Award in 2013.
Page 3 of 26
Prof Will Irving, Professor of Virology established ‘Trent HCV cohort’ in 1992; with the involvement of
Drs Steve Ryder and Brian Thomson, this cohort has contributed to research of international
importance in the last 2 decades. Recently Prof Irving set up HCV research UK, a national consortium
with an ambition of collating 10,000 HCV patients; HCV research UK is hosted by Nottingham Digestive
Diseases BRU. Patients and infrastructure of HCV research UK supports ‘STOP-HCV’, another MRC
funded programme that aims to stratify HCV patients with in-depth phenotyping to optimize therapy.
Prof Jonathan Ball leads the anti-HCV monoclonal antibody discovery programme; currently a EUFP7
funded study is evaluating the role of human monoclonal antibody in the prevention of post-transplant
HCV. Prof Ball also leads pre-clinical evaluation of HCV vaccine candidates.
Professor Robin Spiller’s research programme in neurogastroenterology focuses on pain and motility
disturbance in IBS. Current projects include colonic MRI imaging and functional assessments in
constipation. There are also ongoing projects studying the role of colonic gas and microbiota in IBS
patients.
Professor Chris Hawkey is interested in inflammatory bowel disease, non-steroidal anti-inflammatory
drugs, cancer prevention and the conduct of clinical trials.
Professor Yash Mahida is interested in mucosal biology (including GI stem cells) and C. difficile
pathogenesis.
We have many other research programmes, in which we are actively working to translate basic science
to clinical practice. These include extensive internationally-competitive research in bacteriology and
virology, as well as research on drug targets, delivery and formulation conducted in our award-winning
School of Pharmacy. Further details of individual academic gastroenterologists and their research
interests can be found at: http://www.nottingham.ac.uk/medicine/about/nddc/index.aspx
Teaching and Organisation
Teaching is a core generic academic skill and the ACL will be expected to take an active role in
contributing to undergraduate medical teaching: this may include lectures, tutorials, assisting with the
organisation of clinical examinations in the Nottingham Medical School undergraduate curriculum and
postgraduate teaching.
Anticipated Academic milestones
3 months
4 months
Project area and Main Supervisor decided (if not already done before taking up post)
Detailed research plan written and presented. Research commenced.
12-16
At least two abstracts submitted to major meetings and/or at least one paper based on
12 months research in Nottingham submitted
24-30
At least two further abstracts submitted to major meetings and/or at least one paper
based on 24 months research in Nottingham submitted
Application made for Intermediate or Senior Research Fellowship from MRC, Wellcome
months Trust, or other funding body
36-48
Leave the scheme to take up an Associate Professor post, but with some flexibility to
complete research or clinical training as appropriate
Clinical Training
During periods of clinical training, the successful candidate will undertake full clinical responsibilities of a
Specialty Trainee on the North (Nottingham-centred) Carousel of the Health Education East Midlands
(HEEM) clinical training rotation in GIM/ Gastroenterology where they will work alongside clinical-track
colleagues to attain their remaining competencies in their Specialty Training. Applicants must, therefore,
be eligible to hold an academic National Training Number (NTN(A)) and show evidence of academic
achievement, including a higher research degree at PhD/DPhil or MD/DM level, and successful outcomes
from previous clinical annual assessments (ARCPs). The post is open to those who are at, or within, 2
years of clinical training of attaining their CCT in specialty or subspecialty. Most benefit from the post will
be obtained by those with at least 1 year of clinical training to complete.
Page 4 of 26
The post will be part of the Health Education East Midlands (North) training programme in GIM and
Gastroenterology. The rotation will be tailored to the training needs and research interests of the
applicant. It is envisaged that these posts will usually be based at the Queens' Medical Centre of the
Nottingham University Hospitals NHS Trust. However, the overriding aim will be to provide the post
holder with the opportunity to develop both their clinical and research expertise within
Gastroenterology, which in some instances may involve working elsewhere within training posts in
Nottingham/Derby/Mansfield. Establishing links with these centres may also provide further research
opportunities, enhance access to clinical material and assist recruitment of patients to clinical trials.
Clinical experience at a district general hospital is also required as part of training requirements and
this will necessitate spending some clinical time out of the main research centre.
The main aim of the clinical component is to complete training in Gastroenterology and obtaining a
CCT. Applicants wishing to pursue dual accreditation in GIM and Gastroenterology will take a full part in
GIM and Gastroenterology "on-call" rotas, equivalent to 50% of the WTE ST3+ posts. However, it is
recognised that applicants may wish to pursue single specialty training in Gastroenterology, in which
case the clinical training will only be in Gastroenterology. The clinical training in inpatient and
outpatient gastroenterology, endoscopy, hepatology or nutrition will be tailored to the research and
clinical interests of the successful applicant, but will not account for more than 50% of their weekly
timetable. Clinical placements will be made according to the educational needs of the individual trainee
to Nottingham (QMC), Derby or Mansfield as explained above.
The Clinical Lecturer will be responsible for day to day management of in-patients under the care of all
the Consultants he/she works with. This will also involve giving consistent and planned support for
other Junior Staff attached to these consultants. All trainees are expected to attend the monthly
training days arranged by the Gastroenterology training programme. They will be also be expected to
attend the three Trent Region teaching days (at Nottingham, Sheffield or Leicester and will be
encouraged to attend other national or international conferences, if and when appropriate). The ACL is
expected to take an active part in audit and other relevant clinical governance activity being
undertaken as part of the training programme, to organise clinical meetings, to contribute to the
management activities of the directorates and to attend appropriate committees within the hospitals;
feedback and counselling session/professional review and these are seen as essential components of
higher medical training. At a ‘firm’ level he/she will be responsible for supervising the day to day work
of ST1-3 trainees and Foundation Doctors.
The rotation will provide training according to the requirements of the Colleges and Faculties and the
Postgraduate Dean's network. The Postgraduate Dean confirms that this placement and/or programme will
have the required educational and Dean's approval at the time of entry in to the programme. At the local
level, Royal College/Specialty tutors work with postgraduate clinical tutors in supervising training. Annual
ARCP assessment of a trainee's progress will be undertaken under the overall guidance of the Specialist
Education Committees. Trainees will be expected to take part in appraisal, feedback and counselling
session/professional review.
Mentoring and Supervisory Arrangements for the Academic Clinical Lecturers (ACL)
It is expected that most applicants for the NIHR Clinical Lecturers’ posts will already have identified an
Academic Supervisor before applying for the post. Otherwise, the lead for academic training in
Gastroenterology (Dr Gordon Moran: gordon.moran@nottingham.ac.uk) will support the new NIHR
Clinical Lecturer in selecting an appropriate Academic Supervisor for their chosen research field. As for
all Specialty Trainees, clinical training will be co-ordinated by the Clinical Training Lead in the hospital
in which the Clinical Lecturer is working under the overall direction of the East Midlands (North)
Training Director, Dr Aida Jawhari. All training will be organised in conjunction with the Academic
Supervisor.
Page 5 of 26
Assessment of Academic/Clinical Competencies and Joint Process Management
All Clinical Lecturers undergo a formal annual academic appraisal to monitor progress and
expectations. An academic report from this is submitted to, and considered by, the joint Clinical
Academic ARCP Panel which monitors progress of Specialty Trainees and Clinical Lecturers each year.
Progress will also be monitored with an internal review at 2 years. In the event that an individual is
unsuccessful in developing their postdoctoral research career or higher educational training within this
timeframe, he/she will re-join the full-time clinical training programme to complete CCT.
Nottingham Digestive Diseases Biomedical Research Unit
More information about the Nottingham Digestive Diseases Centre is available at:
http://www.nottingham.ac.uk/medicine/about/nddc/index.aspx
Information on the University of Nottingham School of Medicine and on the City of Nottingham is given
in the Appendices at the end of this document.
DETAILS OF PARTICIPATING HOSPITALS
NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST: QUEEN’S MEDICAL CENTRE
University Hospital (Queen’s Medical Centre) is a major teaching hospital with a total of 1272 beds and
is the major accident and emergency centre for Nottingham.
The hospital forms part of the Queen's Medical Centre, which also houses the Faculty of Medicine and
associated academic groups, including academic gastroenterology. Greenfield Medical Library, one of
the largest medical libraries in the Midlands, is also housed in Queens Medical Centre.
The Gastroenterology firm consists of Consultants with varying specialist clinical and research interests,
which include, intestinal infections (especially H. pylori and C. difficile infections), hepatobiliary disease,
inflammatory bowel disease, neurogastroenterology, gastrointestinal endoscopy, nutrition and coeliac
disease. The firm includes 8 NHS consultants, 4 Associate Professors and 5 Professors, 3 F1s, 1 F2, 4
ST1s or 2s, 4 ST3+ and one other Clinical lecturer at present (in addition to this post).
The 4 ST3+ along with Lecturer(s) share the inpatient and outpatient care of patients with acute and
chronic medical and gastrointestinal problems, including the provision of specialist services in
inflammatory bowel disease, hepatobiliary disease, nutrition and endoscopy. There are separate rotas
for acute gastroenterology and GIM to which at present SPRs contribute in the day for acute
gastroenterology and out of hours for GIM.
An example of the work programme is as follows:
Monday
Tuesday
am
9-11 Ward work
11-1300
Research &
Education
9-11 Ward work
11-1300
Research &
Education
pm
MDT meeting
followed by
Endoscopy list
1400-1700
Research &
Education
Wednesday
Thursday
Friday
OP
9-11 Ward work
11-1300
Research &
Education
2 hr
Gastroenterology
meeting
1400-1700
Research &
Education
OP
1400-1700
Research &
Education
The NUH Digestive Diseases and Thoracic Directorate
Recent service reconfiguration has allowed the opportunity to develop a directorate with medical and
surgical sub-specialities integrated along the lines of care pathways rather than historical boundaries.
The new integrated directorate will allow service provision, resource utilization and operational
management to be more streamlined and efficient. Managerial structure of the directorate is as followsClinical Director
Dr Iain Cameron
Page 6 of 26
Directorate General Manager
Assistant General Manager
Medical Services Manager
Directorate Finance Manager
Deputy Finance Manager
Directorate HR Manager
Directorate Clinical Lead
Matrons
Clinical Heads of service leads:
Ms Gail Walder
Mr Richard Doane
Miss Rachael Briggs
Ms Candice Roberts
Ms Gurpreet Mahal
Mrs Debbie Hunt
Mrs Anne Scott
Sr J Barker, Sr R Patel & Dr G Elwood
Gastroenterology & Nutrition– Dr Martin James
Endoscopy- Professor K Ragunath
Upper GI- Simon Parsons
Thoracic – Mr J P Duffy
HPB – Mr D Gomez
Colorectal – Mr C Maxwell-Armstrong
Directorate Medical Staff
Luminal
NHS Staff
University Staff
Hepatology
NHS Staff
University Staff
GI/Hepatology/GIM
GI Epidemiology
NHS Staff
University Staff
Hepatopancreaticobiliary
Surgery
NHS & University Staff
Colorectal surgery
NHS Staff
University Staff
Upper GI Surgery
NHS Staff
Thoracic
NHS Staff
Dr K Teahon
Dr A Jawhari
Dr T Bowling
Dr S Samuel
Professor J C Atherton
Professor Y R Mahida
Professor R C Spiller
Professor K Ragunath
Dr G Moran (Associate Professor)
Dr S D Ryder
Dr M James
Dr E Wilkes
Professor Guru Aithal
Dr I N Guha (Associate Professor)
Dr N Lewis
DR J West (Dept of Public
Health)(Associate Professor)
Dr T Card (Associate Professor)
Mr I J Beckingham
Mr A Brooks
Professor D N Lobo
Mr I Cameroon
Mr D Gomez
Mr C Macutkiewicz (Locum consultant)
Mr J F Abercrombie
Mr C Maxwell-Armstrong
Mr M H Robinson
Mr J P Williams
Mrs K Walter
Mr A Banerjea
Professor J H Scholefield
Mr A Acheson (Associate Professor)
Mr N T Welch
Mr S L Parsons
Mr J Catton
Mr A Martin-Ucar
Mr J P Duffy
Mr A Majewski
Ms E Internullo
Page 7 of 26
Conditions of Service and Governance
The successful candidate will be offered an Honorary Contract with Nottingham University Hospitals
NHS Trust under their terms and conditions. When undertaking clinical duties on this basis within the
Trust, the person appointed will be expected to adhere to local policies and procedures and to take
note of the standing orders and financial instructions of the Trust. Nottingham University Hospitals
NHS Trust is committed to the development of Clinical Governance. The approach taken is to develop
actions plans at a Directorate level. Each member of the medical staff is expected to take an active
role in clinical governance activities within their Directorate and each Directorate has a Consultant
nominated as Clinical Governance lead. The activities include (but are not restricted to) audit, incident
reporting, review of complaints, risk management, CPD and Evidence Based Practice.
Professional Standards
The Clinical Director (Mr Anwar Zaman) is managerially responsible for all activity and personnel in the
Directorate in which the appointee will work. The Medical Director, Dr Stephen Fowlie, has overall
responsibility for the professional performance of clinicians, including of those holding Honorary
Contracts with NUH. All clinicians are expected to comply with management arrangements in place, to
follow the guidelines on practice laid down by the General Medical Council’s “Maintaining Good Medical
Practice”, and to be accountable to the Trust for their actions and the quality of their work. A yearly
Joint Clinical and Academic Appraisal is carried out.
Information on other Trusts in which the Clinical Lecturer may undertake placements during their
clinical training follow.
DERBY HOSPITALS NHS FOUNDATION TRUST
The GI unit at the Royal Derby Hospital has 3 consultant hepatologists and 6 luminal
gastroenterologists, in addition to 2 F1s, 2 F2s, 2 ST1/2s and 4 SPRs. Specific training opportunities in
Derby include hepatology, interventional endoscopy (including laser, APC, PDT and stent insertion),
endoscopic ultrasound and ERCP. Derby has a graduate entry Medical School based on the Derby City
site and all members of the team take an active part in both pre-clinical and clinical teaching. We also
have an active research unit with current research areas including inflammatory bowel disease,
Barrett’s oesophagus, portal hypertension, celiac disease and endoscopy tumour palliation.
Proposed weekly timetable: (This assumes block release for academic work.)
Monday
Tuesday
Wednesday
Thursday
Friday
am
GI Clinic
GI meeting
Consultant
ward round
SpR ward
round/
MDT
Consultant WR
Grand round
Admin /Ward
pm
Admin/
Endoscopy
Admin/ward
GI Clinic
X ray meeting
Ward work
(1-2pm)
Endoscopy
SHERWOOD FOREST HOSPITALS TRUST: THE KING'S MILL CENTRE
The King's Mill Centre provides the acute medicine and outpatient services for the towns of Mansfield,
Sutton in Ashfield and the surrounding population. Appointees will gain wide experience in general
medicine, working in a team of 4 consultant Gastroenterologists, 1 Associate Professor 2 F1s, 2 F2s, 2
ST1/2s and 2 SPRs.
Page 8 of 26
A proposed weekly timetable is given below. (This assumes block release for academic work.)
Monday
Tuesday
Wednesday
Thursday
Friday
am
Consultant
WR
XRAY meeting
Admin/ ward
work
SPR ward
round
Grand round
Consultant WR
Colorectal MDT
Journal Club/
Clinical cases
ERCP/
Endoscopy
pm
Endoscopy
OP
Admin/ ward
work/ audit and
clinical
governance
meetings
OP
Admin/ ward
work
Person Specifications for Candidates Applying for an Academic Clinical Lectureship in
Gastroenterology
Applicants must have all of the essential criteria listed in BOTH the academic person specification AND
the appropriate clinical person specification (ST3+ depending on the level of training at entry).
The post is only open to those eligible to hold an academic National Training Number who
will have maximum of 2 years and minimum of 1 year of clinical training to complete before
attaining their CCT in specialty or subspecialty on 31 March 2015.
The clinical person specification can be found at:
http://specialtytraining.hee.nhs.uk/files/2013/03/2014-ST3-gastroenterology-person-specificationv3.0.pdf
The academic person specification for the ACL in Gastroenterology is provided below.
ACADEMIC PERSON SPECIFICATION FOR CANDIDATES APPLYING FOR A CLINICAL
LECTURESHIP in GASTROENTEROLOGY AS PART OF INTEGRATED ACADEMIC TRAINING
ESSENTIAL
DESIRABLE
WHEN EVALUATED
ELIGIBILITY
 Evidence of achievement  Evidence of
Application form
of Foundation
commitment to
competences or
specialty.
equivalent.
 Intercalated honours
 Must hold a higher
degree and/or
research degree (MD,
additional qualifications
PhD or equivalent) in
e.g. MSc etc.
a relevant subject
area.
 Evidence of good
progress in clinical
training and that
completion of specialty
training may be
accommodated either
during or after the 4 year
period of the NIHR CL
award.
 Candidate must have
less than or equal to 2
Page 9 of 26
ACADEMIC PERSON SPECIFICATION FOR CANDIDATES APPLYING FOR A CLINICAL
LECTURESHIP in GASTROENTEROLOGY AS PART OF INTEGRATED ACADEMIC TRAINING
ESSENTIAL
DESIRABLE
WHEN EVALUATED
years, but more than one
year of, clinical training
remaining before the
award of Certificate of
Completed Training
(CCT).
KNOWLEDGE &
 Demonstration of
 Knowledge of the
Application form and
ACHIEVEMENTS
acquisition of the level of
centre hosting the
selection centre
knowledge and skills
research and how this
necessary for the
is best placed to
achievement of
support the research,
Foundation and clinical
education and training
competencies or
needs.
equivalent (matched to
 Prizes or distinctions.
the entry level).
 Presentation of work at
 Demonstration of
national or
understanding of, and
international meetings.
commitment to, an
 Significant publications
academic career.
in peer reviewed
 Demonstration of the
journals.
potential for scientific
independence and the
ability to lead a research
team.
 Potential to become a
leader in chosen field.
EDUCATIONAL &
 Demonstration of
Application form
PERSONAL
understanding and
ASPECTS
commitment to academic
career.
 Indication of medium and
long-term career goals.
 Demonstration of
educational reasons for
applying for Clinical
Lectureship Programme.
PROFESSIONAL
 Evidence of team
Application form and
SKILLS
working skills.
selection centre
 Evidence of leadership
potential.
LEGAL
 Satisfactory Enhanced
disclosure from the
Disclosure and Barring
Service.
 GMC registration with a
licence to practise.
Because of the nature of the work, this post is exempted from the provisions of Section 4 (2) of the
Rehabilitation of Offenders Act 1974 by virtue of the Rehabilitation of Offenders Act 1974 (Exceptions)
Order 1975.
Page 10 of 26
Applicants are, therefore, not entitled to withhold information about convictions, which for other
purposes are “spent” under the provisions of the Act, and in the event of employment any failure to
disclose such convictions could result in dismissal or disciplinary action by the University. Any
information given will be strictly confidential and will be considered only in relation to an application for
positions to which the Order applies. This post cannot be taken up until satisfactory enhanced
disclosure has been received. If once employed, an employee receives a conviction, they are required
to inform the University and the Trust.
Due to the requirements of the UK Border and Immigration Agency, applicants who are not UK or EEA
nationals and whose immigration status entitles them to work without restriction in the UK will be
considered on an equal basis with UK and EEA nationals. Please visit
http://www.ukba.homeoffice.gov.uk/ for more information.
Further information for applicants to the ACL post in GASTROENTEROLOGY
Candidates are strongly encouraged to make informal enquiries and should contact Dr Moran in the
first instance:
Dr Gordon Moran, Academic Programme Director
Clinical Associate Professor and Honorary Consultant Gastroenterologist, Clinical Training Lead for the
Nottingham Digestive Disease Centre, NIHR Nottingham Digestive Diseases Centre, Biomedical
Research Unit, D1406, West Block, Queen's Medical Centre, Nottingham NG7 2UH. Telephone: +44
(0)115 9249924 ext 70608; email: Gordon.Moran@nottingham.ac.uk
Information on the Clinical Training Aspects of the Post may be addressed to:
Dr Aida Jawhari, Clinical Training Programme Director
Nottingham University Hospitals QMC campus, D Floor South block, opposite endoscopy
Derby Road NG72UH, Telephone 0115 9249924 ext 66292/6; e-mail: aida.jawhari@nuh.nhs.uk
Guidance on Academic Clinical Lectureships is available from
http://www.nihr.ac.uk/funding/cl-information-for-applicants.htm
The University’s Clinical Academic Training Programme Directors, Professor Helen Budge and Professor
Simon Johnson are also able to provide advice on the training programme.
see website: www.nottingham.ac.uk/go/catp
Please note that applications sent directly to these email addresses will not be considered.
Potential Applicants should also view the Appendices at the end of this document.
Page 11 of 26
THE UNIVERSITY OF NOTTINGHAM
ROLE PROFILE
Job Title:
NIHR Academic Clinical Assistant Professor (ACL)
in Medical Oncology
School/Department:
School of Medicine - Division of Cancer and Stem Cells
Salary:
£31,301 - £54,199 per annum, depending on skills and experience
Contract Status:
This post will be offered on a fixed-term contract for a period of 4 years (if
full-time; up to a maximum of 6 years part-time) or until award of
Certificate of Completion of Training (CCT), whichever is the shorter
Successful applicants must be in post before 31 March 2015
Hours of Work:
Full-time or Part-time (minimum 0.6FTE)
Location:
City Hospital Campus, Nottingham
Reporting to:
Head of Academic Unit of Clinical Oncology
The University of Nottingham seeks applications for an NIHR-funded Academic Lecturer (ACL) in
Medical Oncology based at the City Hospital Campus of the University of Nottingham and Nottingham
University Hospitals NHS Trust. The post is offered in competition with eligible applicants in
Gastroenterology. The post is designed for Academic Clinicians to allow them to continue and complete
higher specialist training in Medical Oncology and combine this with postdoctoral Cancer Research. The
applicants should have a record of successful research and must possess a higher degree (PhD or
research MD).
The Post
The Post provides an excellent opportunity for somebody seeking a long term career in Academic
Oncology. The Post will provide 50% clinical training and 50% research overall but time allocated to
clinical training and to academic work may be annualised, i.e. taken in blocks, as appropriate to
successful candidate’s clinical and research training needs. Clinical training will be tailored for the
successful candidate to allow them to complete their clinical training to obtain a CCT in Medical
Oncology. The post holder will join an existing research grouping either with their own research
proposal or one developed in conjunction with research teams in Nottingham.
The successful ACL will become a member of the well-developed Clinical Academic Training Programme
in the School of Medicine, University of Nottingham (www.nottingham.ac.uk/go/catp). The programme
provides support in integrated clinical academic training, with research funding applications, through
networking, mentorship and with an annual research conference bursary.
The post holder will join an existing research grouping either with their own research proposal or one
developed in conjunction with research teams in Nottingham. During the academic component of the
post, the ACL will further develop their academic skills at postdoctoral level, build on their research in
Medical Oncology, undertake research, develop their own research programme and compete for
external grant funding.
During periods of clinical training, the successful candidate will carry the full clinical responsibilities of a
Specialty Trainee on the North (Nottingham-centred) Carousel of the Health Education East Midlands
(HEEM) clinical training rotation in Medical Oncology where they will work alongside clinical-track
colleagues to attain their remaining competencies in their Specialty Training.
Page 12 of 26
Applicants must, therefore, be eligible to hold an academic National Training Number (NTN(A)) and show
evidence of academic achievement, including a higher research degree at PhD/DPhil or MD/DM level, and
successful outcomes from previous clinical annual assessments (ARCPs).
The post is open to those who are at, or within, 2 years of clinical training of attaining their CCT in
specialty or subspecialty. Most benefit from the post will be obtained by those with at least 1 year of
clinical training to complete. Whilst the post will be offered on a fixed term contract for a period of up to
4 years, or until award of CCT whichever is shorter, the candidate would be expected to develop plans
for a post-doctoral or clinician scientist award, which may shorten the lectureship. An Honorary
Specialty Registrar contract will be sought from Nottingham University Hospitals NHS Trust.
Research
The ACL will be expected to develop, and work within, a programme of high quality competitive
research, publish in quality peer review journals and be capable of securing external funding. Research
may include clinical and/or laboratory based research programmes. There is no other specific area of
cancer research that is targeted for this post but it is important that the research complements existing
research strengths within the University. Initial support for research will be provided to allow the
successful candidate to apply for future independent research funding.
The ACL would be expected further develop their track record in research and will have access to the
research facilities in the School of Medicine which has excellent laboratory and clinical trials support. They
will be expected to undertake research and, as part of their research portfolio, they will be expected to
develop skills in research supervision through the supervision of the research component in the 3rd year
of the BMedSci medical student degree.
Cancer research strengths in Nottingham include, among others, basic cancer biology, mechanisms of
blood vessel growth and permeability in cancers, drug development, tumour immunology, DNA repair, preclinical models, imaging, early diagnosis and palliative care. The research attracts external grant
funding from MRC, BBSRC, CRUK, Wellcome Trust amongst others. There is very active clinical trials
programme with over 50 cancer clinical trials open ranging from Phase I-III trials.
Cancer research strengths in Nottingham include, among others, basic cancer biology, drug
development, tumour immunology, DNA repair, pre-clinical models, imaging, early diagnosis and
palliative care. The research attracts external grant funding from MRC, BBSRC, CRUK, Wellcome Trust
amongst others. There is very active clinical trials programme with over 50 cancer clinical trials open
ranging from Phase I-III trials. More details of the research in the Division of Cancer and Stem Cells
are given below.
Information about research in the School and the Division can also be found at:
http://www.nottingham.ac.uk/medicine/index.aspx
and
http://www.nottingham.ac.uk/medicine/about/cancerandstemcells/index.aspx respectively.
Teaching
Teaching is a core generic academic skill and the ACL will be expected to take an active role in
contributing teaching both undergraduate and graduate students on the University’s Medical Course and
on postgraduate MSc courses.
The Academic Unit of Clinical Oncology runs 2 very successful MSc research courses. The MSc in
Medical Oncology course provides training for speciality registrars in the East Midlands, and basic
scientists from across the world. The MSc in Cancer Immunology is one of the few postgraduate cancer
immunology courses in the country. The Nottingham Medical Course includes special study clinical
attachments in Oncology. The BMedSci is an integral part of the undergraduate five-year medical
course and all students pursue a research project learning to appraise scientific papers and research
methodology. The unit has several BMedSci projects running every year.
Page 13 of 26
Clinical Duties
This post combines protected time for post-doctoral cancer research with clinical training in Medical
Oncology. The Academic Clinical Lecturer will have responsibility of clinical care at ‘Specialty Trainee’
level within the Nottingham University Hospitals NHS Trust, Department of Clinical Oncology. As part
of their clinical training, the post holder will rotate through different site specialist teams as required by
their clinical training needs. They will be expected to carry out the duties of a higher Specialty Trainee,
providing support in clinics and on inpatient wards and to provide support for the junior staff. The
Academic Clinical Lecturer will also take part in out-of-hours (on call) clinical duties as part of an on call
rota and be expected to cross cover other trainees in certain instances.
OUTLINE JOB PLAN
The exact details of the job plan will depend on the nature of the research and the level of training of
the appointee. As an example, this is Job Plan is for the ACL while working in the Melanoma / Renal
cancer team. A similar, but different, Job Plan will be arranged for each part of the clinical rotation.
AM
PM
MON
Research
Outpatient Clinic
TUE
Research
Outpatient Clinic
WED
Research
Research
THU
Education, Audit
Admin
FRI
MDT. WR
Research
Academic Duties
The ACL will be able to explore their research programme with support and supervision from senior
academics in the Division of Cancer and Stem Cells. The ACL will be able to access research
opportunities as part of the Division of Cancer and Stem Cells and in the wider Cancer Research activity
at University of Nottingham.
Cancer Biology Unit
The Cancer Biology Unit within the Division of Cancer & Stem Cells is a multi-disciplinary research
centre working on biological basic of cancer, failure of anti-cancer drugs in early clinical trials, cancer
genetics and stem cell biology. Translation of new findings on mechanisms and cancer processes into
novel therapeutic approaches for cancer and other diseases are research priorities.
Academic Staff of the Cancer Biology Unit
Professor David Bates, Professor of Oncology
Dr Anna Grabowska, Associate Professor
Dr Abdolrahman Shams-Nateri, Associate Professor
Roya Babaei-Jadidi, Andrew Benest, Maria Machado, Research Fellows
Professor David Bates in the Head of the Cancer Biology Unit which sits within the Division of Cancer
and Stem Cells (Head: Professor Poulam Patel). More information is available at:
http://www.nottingham.ac.uk/research/groups/cancerbiology/index.aspx
Academic Unit of Clinical and Translational Oncology
The Academic Unit of Clinical and Translational Oncology is part of University of Nottingham’s Division
of Cancer and Stem Cells, and is based predominantly in purpose built Oncology facilities at the
Nottingham City Hospital Campus. There is currently 845 m2 of space consisting of eight laboratories
(265 m2), including three designed for research, three isotope rooms and two tissue culture
Page 14 of 26
laboratories, additional rooms associated with the laboratories, data handling room and offices
(359m2).
http://www.nottingham.ac.uk/medicine/about/cancerandstemcells/index.aspx
There are 5 research groups, 4 laboratory groups and 1 in palliative care.
Academic Staff of the Academic Unit of Clinical and Translational Oncology
Professor Poulam Patel, Professor of Clinical Oncology
Professor Lindy Durrant, Professor of Cancer Immunotherapy
Dr Andrew Wilcock, Clinical Reader in Palliative Care
Dr Srinvasan Madhusudan, Clinical Associate Professor in Medical Oncology
Dr Stewart Martin, Reader in Cancer and Radiation Biology
Dr Ian Spendlove, Associate Professor
Dr Andrew Jackson, Associate Professor
Dr Judith Ramage, Lecturer
Professor Poulam Patel is the Head of the Academic Unit of Clinical Oncology with overall responsibility
for management and delivery of teaching and research supervision in the Oncology Department. The
Unit of Academic Oncology within the Division of Cancer and Stem Cells is also headed by Professor
Patel. The Dean of the School of Medicine is Professor John Atherton.
Whilst a wealth of research opportunities is available, specific examples of Clinical Research include:
i)
Clinical Trials
The Academic Unit of Clinical and Translational Oncology, in Partnership with the NHS
Department of Clinical Oncology and the local National Cancer Network, has a state of the
art Cancer Clinical trials team. The group is a 50 person strong multidisciplinary team of
research nurses and radiographers, data managers and ethic and finance managers and
carries out both simple and complex clinical trials according the highest standards of Good
Clinical Practice. With over 50 open clinical trials and >1000 patients entered into trials in
the last 3 years we have an annual financial turnover of >£0.5M. We conduct Phase I to III
trials in the majority of tumour types and the close proximity of the clinic to the laboratory
facilitates sample collection for translation studies, an essential part of many new targeted
therapy trials in cancer
ii)
Tumour Host-Cell Interactions - Professor Poulam Patel, Dr Andrew Jackson
Our research focuses on understanding how tumours suppress the immune system and
devising novel ways to restore immune function. We recently identified alterations in
molecular signalling pathways of dendritic cells (DC) induced by tumours and showed that
these pathways can be drugged to restore appropriate immune function. We are currently
investigating the clinical application of MAPK-inhibitors in manipulating DC function in cancer
& the role of intracellular stress signals in modifying immune responses. A key focus of our
group is the translation of our basic observations to clinical application. In this regard, we
have a track-record of translation from basic laboratory research into clinical trials in
patients with advanced cancer and are ideally placed to take advantage of the Clinical
Cancer Centre.
iii)
Immunotherapy Group - Professor Lindy Durrant, Dr. Ian Spendlove, Dr. Judith Ramage
The Immunotherapy group have 2 main focus areas:.
- development of monoclonal antibodies and
- cancer vaccines to novel tumour antigens.
Our access to primary human tumour tissues enables us to use this resource to develop
unique antibodies/vaccines. We are currently developing antibodies/vaccines to aberrant
glycolipids and glycoproteins that are uniquely expressed by tumours. This involves
purification and characterisation of these reagents for immunisation and assay. We then
optimise therapeutic potential of Mabs by cloning and engineering to maximize effector
Page 15 of 26
mechanisms including complement and cell mediated cytotoxicities. We have developed
assays to investigate and validate these responses. We then have access to a range of
therapeutic models in order to test anti tumour responses.
Our second area of expertise is in generating regulatory immune responses within the
tumour environment. Here we have models Tregs, toleragenic DC and tumour vasculature.
We have a unique in vitro model of generating Tr1 regulatory T cells via the CD55 costimulatory pathway, identifying CD55 and its counter receptor (CD97) as key mediators in
Tr1 differentiation. We have established endothelial transmigration assays to demonstrate
that tumour conditioning results in the preferential recruitment of Tregs to tumours where
they suppress effective immune responses. This work is carried out with both primary
human T cells and therapeutic models where we are able to study T cell tumour interactions
in vivo and in vitro.
These are brought together to enable a targeted approach to the analysis of host tumour
interactions with the aim of identifying novel drug targets and modes of reversing the
immune-inhibitory tumour environment.
iv)
Translational Radiation Biology Group- Dr Stewart Martin
Research in the TRBR group focuses upon lymphatic biology, particularly how it relates to
metastatic dissemination of cancer (primarily breast cancer and melanoma), and regulation
of redox homeostasis, principally the role that redox proteins play in modulating cancer cell
response to therapy, both radiotherapy and chemotherapy. The acquisition of the Wellcome
Trust funded cabinet irradiation facility will allow a significant expansion of this latter area
and allow additional collaborative ventures to be instigated, examining molecular responses
of how cells respond to ionizing radiation, how these can be modulated to increase tumour
cell kill but minimising normal cell lethality, and also how radiation may be combined with
novel chemotherapy agents to increase therapeutic efficacy. We have a broad range of local,
national and international collaborations
v)
Translational DNA Repair Group – Dr Srinivasan Madhusudan
The anti-cancer activity of many chemotherapeutic agents and ionizing radiation is directly
related to their ability to induce DNA damage in tumour tissue. Cellular responses to DNA
damage are complex but the ultimate fate of the cell is dictated by its ability to repair such
damage; extensive unrepairable DNA damage promoting cell death and efficient DNA repair
promoting cell survival. This would imply that proficient DNA repair in tumours could
contribute to therapeutic resistance. Pharmacological inhibition of DNA repair may improve
therapeutic response and improve patient outcomes.
The main aim of our group is to develop small molecule inhibitors of Human AP
endonuclease 1 (APE1) a critical protein involved in DNA Base excision repair that is involved
in the repair of DNA damage induced by alkylating agents. To achieve this goa,l we have
used molecular modelling, virtual screening, fluorescence based high through-put screening,
DNA repair biochemical assays and cell based cytotoxicity investigations. In addition to drug
discovery research, our group is focussed on developing predictive biomarkers of response
to chemotherapy in gastro-intestinal cancer patients. We have developed and employed high
throughput tissue microarray (TMA) based investigations focussed on DNA repair pathways
to achieve this goal.
NHS DEPARTMENT OF ONCOLOGY
The Department of Clinical Oncology is part of the Cancer and Associated Specialties Directorate at the
Nottingham University Hospital NHS Trust and Dr Daniel Saunders is the Head of Service for the NHS
Oncology Service.
The Department serves a resident population of 1.1 million and currently sees approximately 3000 new
patients each year; providing a comprehensive range of non-surgical Oncology services to the East
Page 16 of 26
Midlands. The Academic Division of Clinical Oncology is based in the Department and, together with
the whole of the Division, strives to deliver the highest standards of treatment and care to patients.
The Department has 5 Medical Oncology and 10 Clinical Oncology Consultants providing site specialist
care in multi-disciplinary teams. There is an established Medical Oncology Higher Specialist Training
programme (3 posts) and a Clinical Oncology programme (currently 7 posts). The department has 2
F1s, 3 F2s and 3 ST1/2 trainees as part of the East Midlands Healthcare Workforce Deanery (North)
training rotations. The Department has 5 NIHR Academic Clinical Fellows in Oncology.
The Department has a very active Clinical Trials programme with a dedicated research team for
academic, NCRN and industry lead studies as well as integral working with the NCRN research team.
There is a commitment from all staff to research, development and clinical audit within the Department
at a multidisciplinary level.
The Department occupies a modern purpose-built block, into which it moved in 1993, having previously
been sited at the former Nottingham General Hospital. We are equipped with:44 in-patient beds (18 on Fraser Ward (plus a 4-bedded day case facility for chemotherapy), 18
on Gervis Pearson Ward and 8 on Bernham.
There is one room on each of Fraser and Gervis Pearson Wards for the administration of sealed or
unsealed radioactive sources and a two-bedded suite on Fraser Ward for brachytherapy (selectron).
There is a new expanded chemotherapy day case facility and a dedicated clinical trials area. Computer
based prescribing using the Chemocare system is in place.
There is a separate oncology outpatients department and oncology pharmacy located within the
Oncology building. We have dietitians, physiotherapists, social workers and occupational therapists
dedicated to the Oncology Unit. There is a Data Management Team with Research Chemotherapy
Nurses and Research Radiographers available to support clinical research. There is a fully equipped and
well staffed Radiotherapy Department. See also Appendix 2.
Consultant Medical Staff:
Dr Victoria Brown, Medical Oncologist – Breast Cancer, Acute Oncology
Dr Kate Cardale, Clinical Oncologist - Lung, Sarcoma,
Dr Steve Chan, Clinical Oncologist - Breast and Gynaecological Cancers
Dr Judy Christian, Clinical Oncologist – Head and Neck cancer
Dr Karen Foweraker, Clinical Oncologist - Lung and Brain Tumours
Dr Eleanor James, Clinical Oncologist - Hepatobiliary Cancer, Upper GI, Lymphoma
Dr Ivo Hennig, Medical Oncologist - Sarcoma, Germ Cell Cancer, Lung Colorectal cancer
Dr Sarah Khan, Medical Oncologist - Breast and Lung Cancers
Dr Pat Lawton, Clinical Oncologist - Breast Cancer and Skin Cancer
Dr Jamie Mills, Clinical Oncologist - Colorectal and Urological Cancers
Dr Sally Morgan, Clinical Oncologist - Lung, GI and Thyroid Cancers
Professor Poulam Patel, Medical Oncologist – Renal cancer and melanoma
Dr Vanessa Potter, Medical Oncologist – Colorectal cancer and Lung cancer
Dr M Sokal, Clinical Oncologist - GU, Sarcomas and Paediatric Cancers
Dr Srinivasan Madhusudan, Medical Oncologist - hepatobiliary cancer, upper GI cancer.
Dr Daniel Saunders, Clinical Oncologist - Paediatric RT, GU Cancers
Dr S Sundar, Clinical Oncologist - GU, Gynaecological Cancers
Junior Medical Staff
10 StRs (3 Medical Oncology, 7 Clinical Oncology),
2 current ACFs ST3, ST4
Mentoring and Supervisory Arrangements for the Academic Clinical Lecturers (ACL)
It is expected that most applicants for the NIHR Clinical Lecturers’ posts will already have identified an
Academic Supervisor before applying for the post. Otherwise, the lead for academic training in Medical
Page 17 of 26
Oncology (Professor Poulam Patel: poulam.patel@nottingham.ac.uk) will support the new NIHR Clinical
Lecturer in selecting an appropriate Academic Supervisor for their chosen research field. As for all
Specialty Trainees, clinical training will be co-ordinated by the Clinical Training Lead in the hospital in
which the Clinical Lecturer is working under the overall direction of the East Midlands (North) Training
Director, Dr Sarah Khan. All training will be organised in conjunction with the Academic Supervisor.
Assessment of Academic/Clinical Competencies and Joint Process Management
The successful candidate will be responsible to the Head of the Academic Unit of Clinical Oncology
through whom they are accountable to the Dean of the School of Medicine and the Dean of the Faculty
of Medicine and Health Sciences at the University of Nottingham. Clinical training will fall under the
auspices of the East Midlands Local Education Training Board (LETB).
All Clinical Lecturers undergo a formal annual academic appraisal to monitor progress and
expectations. An academic report from this is submitted to, and considered by, the joint Clinical
Academic ARCP Panel which monitors progress of Specialty Trainees and Clinical Lecturers each year.
In the event that an individual is unsuccessful in developing their postdoctoral research career or
higher educational training within this timeframe, he/she will re-join the full-time clinical training
programme to complete CCT.
Person Specifications for Candidates Applying for an Academic Clinical Lectureship in
Medical Oncology
Applicants must have all of the essential criteria listed in BOTH the academic person specification AND
the appropriate clinical person specification (ST3+ depending on the level of training at entry).
The post is only open to those eligible to hold an academic National Training Number who
will have maximum of 2 years and minimum of 1 year of clinical training to complete before
attaining their CCT in specialty or subspecialty on 31 March 2015.
The clinical person specification can be found at:
http://specialtytraining.hee.nhs.uk/files/2013/03/2015-PS-Medical-Oncology-ST3-1-0.pdf
The academic person specification for the ACL in Medical Oncology is provided below.
ACADEMIC PERSON SPECIFICATION FOR CANDIDATES APPLYING FOR A CLINICAL
LECTURESHIP in MEDICAL ONCOLOGY AS PART OF INTEGRATED ACADEMIC TRAINING
ESSENTIAL
DESIRABLE
WHEN EVALUATED
ELIGIBILITY
 Evidence of achievement  Evidence of
Application form
of Foundation
commitment to
competences or
specialty.
equivalent.
 Intercalated honours
 Must hold a higher
degree and/or
research degree (MD,
additional qualifications
PhD or equivalent) in
e.g. MSc etc.
a relevant subject
area.
 Evidence of good
progress in clinical
training and that
completion of specialty
training may be
accommodated either
during or after the 4 year
period of the NIHR CL
award.
 Candidate must have
Page 18 of 26
ACADEMIC PERSON SPECIFICATION FOR CANDIDATES APPLYING FOR A CLINICAL
LECTURESHIP in MEDICAL ONCOLOGY AS PART OF INTEGRATED ACADEMIC TRAINING
ESSENTIAL
DESIRABLE
WHEN EVALUATED
less than or equal to 2
years, but more than one
year of, clinical training
remaining before the
award of Certificate of
Completed Training
(CCT).
KNOWLEDGE &
 Demonstration of
 Knowledge of the
Application form and
ACHIEVEMENTS
acquisition of the level of
centre hosting the
selection centre
knowledge and skills
research and how this
necessary for the
is best placed to
achievement of
support the research,
Foundation and clinical
education and training
competencies or
needs.
equivalent (matched to
 Prizes or distinctions.
the entry level).
 Presentation of work at
 Demonstration of
national or
understanding of, and
international meetings.
commitment to, an
 Significant publications
academic career.
in peer reviewed
 Demonstration of the
journals.
potential for scientific
independence and the
ability to lead a research
team.
 Potential to become a
leader in chosen field.
EDUCATIONAL &
 Demonstration of
Application form
PERSONAL
understanding and
ASPECTS
commitment to academic
career.
 Indication of medium and
long-term career goals.
 Demonstration of
educational reasons for
applying for Clinical
Lectureship Programme.
PROFESSIONAL
 Evidence of team
Application form and
SKILLS
working skills.
selection centre
 Evidence of leadership
potential.
LEGAL
 Satisfactory Enhanced
disclosure from the
Disclosure and Barring
Service.
 GMC registration with a
licence to practise.
Because of the nature of the work, this post is exempted from the provisions of Section 4 (2) of the
Rehabilitation of Offenders Act 1974 by virtue of the Rehabilitation of Offenders Act 1974 (Exceptions)
Order 1975. Applicants are, therefore, not entitled to withhold information about convictions, which for
other purposes are “spent” under the provisions of the Act, and in the event of employment any failure
Page 19 of 26
to disclose such convictions could result in dismissal or disciplinary action by the University. Any
information given will be strictly confidential and will be considered only in relation to an application for
positions to which the Order applies. This post cannot be taken up until satisfactory enhanced
disclosure has been received. If once employed, an employee receives a conviction, they are required
to inform the University and the Trust.
Due to the requirements of the UK Border and Immigration Agency, applicants who are not UK or EEA
nationals and whose immigration status entitles them to work without restriction in the UK will be
considered on an equal basis with UK and EEA nationals. Please visit
http://www.ukba.homeoffice.gov.uk/ for more information.
Further information for applicants to the ACL post in MEDICAL ONCOLOGY
Candidates are strongly encouraged to make informal enquiries and should contact Professor Patel in
the first instance:
Academic Programme Director: Professor Poulam Patel (poulam.patel@nottingham.ac.uk)
Information on the Clinical Training Aspects of the Post may be addressed to:
Clinical Training Programme Director: Dr Sarah Khan (sarah.khan@nuh.nhs.uk)
Guidance on Academic Clinical Lectureships is available from
http://www.nihr.ac.uk/funding/cl-information-for-applicants.htm
The University’s Clinical Academic Training Programme Directors, Professor Helen Budge and Professor
Simon Johnson are also able to provide advice on the training programme.
see website: www.nottingham.ac.uk/go/catp
Please note that applications sent directly to these email addresses will not be considered.
Potential Applicants should also view the Appendices at the end of this document.
Appendix 1
The University of Nottingham
The University of Nottingham is a global-leading, research-intensive university with campuses in the
UK, Malaysia and China. Our reputation for world-class research has yielded major scientific
breakthroughs such as Nobel-winning MRI techniques, drug discovery, food technologies and
engineering solutions for future economic, social and cultural progress.
Already ranked among the UK’s elite universities and global polls for research excellence, our
reputation for world-class research has been further enhanced with the 2008 results of the Research
Assessment Exercise (RAE).
In addition to scoring highly in quality rankings covering major disciplines in science, engineering, the
social sciences, medicine, business and the arts, it is Nottingham’s increase in research power rankings
which demonstrate the impressive volume of excellent research which is carried out. We are now
ranked in the Top 7 of all British universities and are one of only two institutions to move into the UK
Top 10 since 2001 – an increase of seven places, making us the highest mover of any university.
Following the UK’s Research Assessment Exercise (RAE) results, 90% of all research at Nottingham has
been classified of an ‘international standard’ and 60% as ‘world-leading’ or ‘internationally excellent’.
The main University campus is set beside a lake, in an extensive belt of woodland, parks and playing
fields. The 330 acre University Park Campus is the focus of life for more than 32,000 students and
houses the majority of the University’s academic schools and many of the central Services. The Jubilee
campus is situated 2 miles away from the University Park, and provides extra capacity. The University
Page 20 of 26
Medical School is situated next to the University Park. Together with the University Hospital, it forms
the Queen’s Medical Centre (QMC).
University of Nottingham Medical School
Nottingham has a strong reputation for both clinical medicine and teaching. As one of the most popular
medical schools in the country, it is able to select excellent students and produce and attract good
junior doctors.
The School of Medicine was formed following Faculty reconfiguration on August 1st 2013. The new
School of Medicine comprises the Divisions of Cancer and Stem Cell, Child Health, Obstetrics and
Gynaecology; Clinical Neuroscience; Epidemiology and Public Health; Primary Care; Psychiatry and
Applied Psychology; Rehabilitation and Ageing; Medical Sciences and Graduate Entry Medicine;
Respiratory Medicine; Rheumatology, Orthopaedics and Dermatology and the Nottingham Digestive
Diseases Centre. The School also hosts the Medical Education Centre, the Centre for Interprofessional
Education and Learning, the Clinical Research Facility, the Clinical Skills Centre, NIHR design Service
East Midlands, Nottingham Clinical Trials Unit, PRIMIS and Medical Imaging Unit.
The new School of Medicine brings together in one School staff undertaking research for the benefit of
the health of patients. It includes all primary care and hospital-based medical and surgical disciplines,
principally in the Queen’s Medical Centre and City Hospital Nottingham Campuses, Royal Derby
Hospitals NHS Foundation Trust and also at the University’s main campus and at the King’s Meadow
and Jubilee Campuses. Most of our School’s Senior Researchers and Teachers are also clinicians who
dedicate 50% of their time to patient care within the Nottingham University Hospitals NHS Trust &
Royal Derby Hospitals NHS Trust. This close juxtaposition brings cutting-edge clinical care to our
patients and clinical relevance to our research and teaching. We are closely integrated with our full
time NHS clinical colleagues, many of whom are themselves leaders in research and teaching and who
work closely with the University and this increases the mutual benefit from integration between the
University and NHS.
Mission:
Our mission is to improve human health and quality of life locally, nationally and internationally
through outstanding education, research and patient care.
Priorities:
1. Teaching and learning, particularly training tomorrow’s doctors and teaching specialised
postgraduates
2. Research and research training: We will perform and support the highest quality “big”
research which impacts on human health and disease
3. Partnership with the NHS and other healthcare providers
4. Visibility and profile of the School of Medicine: We will do what we do better, and we will
tell others about it
Ethos and principles:
1. Having people and patients at the heart of all we do: our teaching and learning, our
research and our patient care
2. Contribution within the School of Medicine and to society beyond our immediate roles;
helpfulness and service
3. Openness and fairness, with particular emphasis on communication (both internal and
external) and on equality and diversity among students and staff
4. Personal and group responsibility for all aspects of our work, within a culture of opportunity
and reward
Our research spans 11 major themes, ranging from cancer to vascular medicine. We work closely with
industry and the NHS. Our world-leading research ranges from basic and translational science through
Page 21 of 26
to clinical trials, epidemiology, and health services research. Our clear theme is improving human
health, underpinning a vibrant postgraduate research training programme leading to PhD or DM. Many
of our academics are clinicians, using their expertise to provide cutting edge specialised treatment to
NHS patients; reflecting our ethos that patients are at the heart of all we do.
Our major research themes are in Cancer and Stem Cells; Child Health, Obstetrics & Gynaecology;
Clinical Neurosciences; Digestive Diseases; Epidemiology and Public Health; Mental Health;
Musculoskeletal and Dermatology; Primary Care; Rehabilitation and Ageing; Respiratory Medicine and
Vascular and Renal Medicine.
The School of Medicine trains tomorrow’s doctors on a vibrant undergraduate medical course with a
unique intercalated BMedSci, as well in a specialised graduate-entry programme built around clinical
problem solving. We teach medicine and related disciplines at both undergraduate and postgraduate
level. We have a dedicated clinical academic training programme and are committed to training PhD
and doctoral research students and to supporting postdoctoral clinicians and scientists in their
research.
Professor John Atherton is Dean of the School of Medicine.
For further information, please see our website http://www.nottingham.ac.uk/medicine
Nottingham
Central within the East Midlands, Nottingham is a vibrant and prosperous city with something to offer
everyone. It is one of the UK’s leading retail centres and has a huge variety of restaurants, bars and
nightclubs which attract people from all over the UK. Culturally, it has good theatres, an arena which
attracts both national and international performers and a range of historical interests relating to
subjects such as the lace industry, Lord Byron and DH Lawrence. Nottingham is also known for sport,
being the home of Trent Bridge Cricket Ground, Nottingham Forest and Notts County Football Clubs,
the National Water Sports Centre and the Nottingham Tennis Centre. There is a good network of roads
with easy access to the M1 and the A1, a fast frequent rail service to London and other major cities.
Nottingham East Midlands Airport is only eighteen miles away.
The city is set within a county of outstanding natural beauty which includes Sherwood Forest, Wollaton
Park, lively market towns and wonderful historic buildings. Housing is relatively inexpensive and, in
addition to the two Universities, there are excellent schools and colleges available.
To find out more about Nottingham, use the following links:
Nottingham County Council – Tourism
http://www.experiencenottinghamshire.com/
University of Nottingham
http://www.nottingham.ac.uk
Zoopla (Guide to local properties)
http://www.zoopla.co.uk/
My Nottingham
http://www.nottinghamcity.gov.uk/article/22779/Homepage
(information on schools, term dates, school transport etc.)
Faculty of Medicine and Health Sciences, University of Nottingham
Comprising of four schools (School of Health Sciences, School of Life Sciences, School of Medicine and
the School of Veterinary Medicine and Science) we undertake research across the full range of health
and basic sciences. Overall we teach around 6,000 undergraduate and 900 postgraduate taught
students, with our courses being recognised for their innovative and exemplary teaching. Our wide
ranging research covers areas from basic sciences to clinical translational research.
Vision
Our vision is to deliver world leading research and inspirational teaching for tomorrow’s scientists,
doctors, nurses, midwives, physiotherapists and veterinarians.
We will achieve this via our:
Page 22 of 26





excellent links with industry and the NHS
talented people – working and learning in a vibrant and supportive academic community
commitment to inspirational teaching
outstanding environment and facilities
advanced research facilities and associated expertise to underpin cutting-edge research
Teaching
Our teaching strategy is to develop graduates who have a thorough grounding in their subject of study,
are aware of research, have a critical approach to knowledge, can study independently and have the
skills and attributes to be successful in employment.
We are particularly keen to ensure that our students have a well-balanced programme of lectures,
small group teaching, tutorials and seminars. Laboratory and practical work are intrinsic parts of our
undergraduate degrees and are highly valued and enjoyed by our students.
Research
Our wide ranging research covers areas from basic sciences to clinical translational research in which
we currently supervise 800 postgraduate research students and undertake research of £43 million per
annum.
The Faculty provides advanced research facilities and associated expertise to underpin cutting-edge
research. These include next generation high throughput gene sequencing and bioinformatics support,
high content screening for drug discovery, and a wide range of imaging modalities such as MRI and PET
CTs, for human and advanced animal research.
The dedicated Clinical Trials Unit and Clinical Research Facility are funded in partnership with
Nottingham University Hospitals NHS Trust.
The Faculty’s research platforms make important contributions in four of the University’s Research and
Knowledge Transfer Strategic Priority Areas:
• Biomedical Imaging
• Clinical Translational Research
• Drug Discovery
• Global Food Security
NHS Partnerships
The work we do depends on strong and effective partnerships with organisations in the East Midlands.
In establishing the new Faculty of Medicine and Health Sciences we aim to make our partnerships with
the NHS even stronger so that our collective research and education activities deliver the greatest
benefits for patients and the public.
Key Facts
 Around 1,700 faculty staff including 1,000 academics
• Over 5,000 students including 3,652 undergraduates (7% international)
• 818 postgraduate taught masters students (22% international)
• 810 research students
• Total research portfolio in excess of £140 million
• Attracted £37.3 million in new awards in 2012-13
• 328 live research projects (2012-13)
Page 23 of 26
Appendix 2
Nottingham and the Nottingham University Hospitals NHS Trust
Nottingham
Central within the East Midlands, Nottingham is a vibrant and prosperous city with something to offer
everyone. It is one of the UK’s leading retail centres, has a huge variety of restaurants, bars and
nightclubs which attract people from all over the UK. Culturally, it has good theatres, an arena which
attracts both national and international performers and a range of historical interests relating to
subjects such as the lace industry, Lord Byron and DH Lawrence. Nottingham is also known for sport,
being the home of Trent Bridge Cricket Ground, Nottingham Forest and Notts County Football Clubs,
the National Water Sports Centre and the Nottingham Tennis Centre. There is a good network of roads
with easy access to the M1 and the A1, the rail service to London and other major cities is frequent and
Nottingham East Midlands Airport is only eighteen miles away.
The city is set within a county of outstanding natural beauty that includes Sherwood Forest, Wollaton
Park, lively market towns and wonderful historic buildings. Housing is relatively inexpensive and, in
addition to the two Universities, there are excellent schools and colleges available.
To find out more about Nottingham, use the following links:
Nottingham County Council – Tourism
http://www.experiencenottinghamshire.com/
University of Nottingham
http://www.nottingham.ac.uk
Zoopla (Guide to local properties)
http://www.zoopla.co.uk/
My Nottingham (information on schools, term dates, school transport etc.)
http://www.nottinghamcity.gov.uk/index.aspx?articleid=8524
Nottingham University Hospitals NHS Trust
The Nottingham University Hospitals NHS Trust is one of the largest hospital Trusts in the UK with an
annual budget of more than £500 million, a total of 2,200 hospital beds across both campuses and over
11,500 staff. NUH is a major teaching Trust, enjoying close links with the region’s Universities and
attracting and developing the highest calibre of staff. The work carried out at NUH has led to a
reputation for excellence and is making a very real difference to people’s lives. NUH is also a cancer
centre – a major element of the Mid-Trent Cancer Network.
The Trust works in close association with the University of Nottingham and the University of Derby.
There are very strong links with nursing and midwifery training, which is part of the University of
Nottingham Faculty of Medicine and Health Sciences, and with the locally-based Schools of
Physiotherapy, Radiology and Radiotherapy.
The following two sections describe the services and facilities currently at the two campuses. However,
there are ongoing discussions about the future development and location of clinical services, as a result
of which some services or parts of services may relocate to the other campus.
1.
City Hospital Campus
The City Hospital Campus offers a wide range of clinical services to the local population of greater
Nottingham, plus a much larger population in such specialties as plastic surgery and burns, cardiothoracic surgery, cancer, renal, breast services, clinical genetics and neonatology.
There is no Accident and Emergency department on the campus, although the hospital does take
medical and surgical emergency patients referred by GPs or from other acute hospitals.
The Nottingham City Hospital campus has a long association with the city of Nottingham. It first
opened in 1903 and the buildings are a mixture of old and new, although services have recently
benefited from huge investment in improving the facilities for patients. These developments include the
purpose-built Endoscopy Centre, Nottingham Breast Institute, Nottingham Urology Centre, Trent
Page 24 of 26
Cardiac Centre, Short Stay Unit, Centre for Clinical Haematology and PET scanner. There are also new
staff residences on site.
Research interests at the City campus include oncology, respiratory medicine, clinical haematology,
rheumatology, diabetes/endocrinology, stroke medicine, urology, breast cancer and mineral
metabolism. Professors in the following specialities are based on this site - Surgical Science,
Respiratory Medicine, Microbial Diseases, Obstetrics and Gynaecology, Oncology, Medical Genetics and
Stroke Medicine. In addition, there are academic departments of Haematology, Rheumatology,
Continuing Care and Anaesthetics.
City Hospital is home to training centres in breast screening techniques and cardiac surgery and the
Trust is a Cancer Centre, forming part of the Mid-Trent Cancer Network.
The City Hospital campus has a variety of facilities for the use of patients, visitors and staff. There is a
restaurant, coffee bars selling hot and cold snacks and hospital shops.
The Nottingham City Hospital Campus of NHS Trust is a major teaching hospital with a total of 1070
beds. It is one of the campuses of the University of Nottingham with academic units in Respiratory
Medicine, Haematology, Medical Oncology, Stroke Medicine, Surgery, Obstetrics and Gynaecology.
In 1999 the Clinical Sciences Building (CSB), a £6M investment, was opened on the City Hospital site.
This was a joint initiative by the NHS and the University of Nottingham to integrate and develop the
academic presence within the City Hospital. The Division of Respiratory Medicine at Nottingham City
Hospital is based in the Centre for Respiratory Research within the Clinical Sciences Building, which
provides excellent, modern accommodation, teaching and laboratory facilities for undergraduate
students and postgraduate work. The CSB has been expanded with a £4M extension to house the
epidemiology group and Tobacco Control Centre.
Excellent facilities for cell and molecular biology research can be found in the Clinical Sciences Building.
The top floor contains 40-50 lab based researchers from 5 groups (Respiratory Medicine/ Haematology/
Tumour Immunology/ Rheumatology/ Infectious Diseases0 working in a suite of state of the art
laboratories with multi-user shared space and individual groups laboratories. Excellent facilities are
available for cell culture and many aspects of cell and molecular biology including FACS scanning, PCR
(including real time), GM work, isotope studies, gene sequencing etc. Nottingham University also has
several technology platforms in genomics/proteomics/metabolomics allowing easy access to these
technologies and transgenic facilities.
There are several new builds as part of the BRU including lung function and a research out-patient
facility. There are excellent bronchoscopy facilities on the City Hospital site and the new BRU has one
fully funded research bronchoscopy list.
2.
Queen’s Medical Centre Campus
As well as the hospital, the QMC building, which opened in 1978, also houses the University of
Nottingham Medical School and School of Health Sciences (incl. Nursing and Midwifery).
Clinical services provided within QMC include a very substantial emergency workload, particularly in
medical admissions. Within the Medical Division services include the Emergency Department, Medicine,
(including Cardiovascular, Respiratory, Gastroenterology, Diabetes and Endocrinology, Haematology,
Rheumatology, Immunology, Palliative Care,) Dermatology, Intensive Care and Health Care of the
Elderly. Within the Surgical Division services include Surgery, (including Vascular, Colorectal and
Hepato pancreatic biliary,) ENT, Ophthalmology, Maxillofacial, Trauma & Orthopaedics, (including
Spinal,) and Neurosciences. Within the Family Health Division, services include Obstetrics and
Fetomaternal Medicine, Gynaecology, (including Fertility Services), Child Health (including Neonatology
and Paediatric Surgery) and Occupational Health.
The QMC site has constantly developed the services it provides to enable it to meet the needs of its
patients both now and for the future. Queen’s has the only Emergency Department for the city. In
Page 25 of 26
2008, the new Nottingham NHS Treatment Centre opened on the QMC campus. The treatment centre is
managed by an independent sector provider.
There are a number of facilities provided in QMC, including a Newsagent, Coffee shop/Sandwich bar,
Clothes shop, Bank (National Westminster, open daily from 10.30 – 3.30pm) and a Pharmacy shop.
There is a large dining area, roof garden and an active Doctors’ Mess with kitchen, PCs with Internet
access, sitting room, billiard tables, and television.
Conditions of Service and Governance
The successful candidate will be offered an Honorary Contract with the Nottingham University Hospitals
NHS Trust under the terms and conditions. When undertaking clinical duties on this basis within the
Trust, the person appointed will be expected to adhere to local policies and procedures and to take
note of the standing orders and financial instructions of the Trust.
Nottingham University Hospitals NHS Trust is committed to the development of Clinical Governance.
The approach taken is to develop actions plans at a directorate level. Each member of the medical
staff is expected to take an active role in clinical governance activities within their directorate and each
directorate has a Consultant nominated as Clinical Governance lead. The activities include (but are not
restricted to) audit, incident reporting, review of complaints, risk management, CPD and Evidence
Based Practice.
Professional Standards
The Clinical Director is managerially responsible for all activity and personnel in the directorate in which
the appointee will work. The Medical Director, Dr Stephen Fowlie, has overall responsibility for the
professional performance of clinicians, including of those holding Honorary Contracts with NUH. All
clinicians are expected to comply with management arrangements in place, to follow the guidelines on
practice laid down by the General Medical Council’s “Maintaining Good Medical Practice”, and to be
accountable to the Trust for their actions and the quality of their work. A yearly Joint Clinical and
Academic Appraisal is carried out.
Postgraduate Facilities
Nottingham University Hospitals NHS Trust fully supports and recognises the importance of continuing
professional development for Consultants and career-grade staff. The facilities available to support this
include two large purpose-built Postgraduate Centres. The Trust encourages consultants to participate
actively in Continuing Medical Education activities both within the Trust and externally and the
provision of study leave is managed by a Trust Study Leave Committee administered within the
Postgraduate Centres.
The Postgraduate Centre at the City Campus provides an excellent educational environment for
multidisciplinary conferences and seminars, postgraduate medical education and continuing medical
education. It also provides a base for the Nottingham Vocational Training Scheme for General Practice,
as well as teaching facilities and common room for undergraduate students of Nottingham University
Medical School and a brand new Clinical Skills Centre.
The Postgraduate Centre at Queen’s Medical Centre Campus contains eleven meeting rooms of varying
sizes and audio-visual equipment including video-conferencing.
Page 26 of 26